The Use of an IL-1 Receptor Antagonist Peptide to Control Inflammation in the Treatment of Corneal Limbal Epithelial Stem Cell Deficiency

Corneal limbal stem cell deficiency (LSCD) may be treated using ex vivo limbal epithelial stem cells (LESCs) derived from cadaveric donor tissue. However, continuing challenges exist around tissue availability, inflammation, and transplant rejection. Lipopolysaccharide (LPS) or recombinant human IL-...

Descripción completa

Detalles Bibliográficos
Autores principales: Fok, E., Sandeman, S. R., Guildford, A. L., Martin, Y. H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4330955/
https://www.ncbi.nlm.nih.gov/pubmed/25705668
http://dx.doi.org/10.1155/2015/516318

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4330955/
https://www.ncbi.nlm.nih.gov/pubmed/25705668
http://dx.doi.org/10.1155/2015/516318

Ejemplares similares